This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Akiko Egami: Innovator in Histone Acetyl Transferase Inhibition
Introduction
Akiko Egami is a prominent inventor based in Musashino, Japan. She has made significant contributions to the field of biochemistry, particularly in the development of compounds that inhibit histone acetyl transferase activity.
Latest Patents
One of her notable patents is related to an EP300/CREBBP inhibitor. The invention provides a compound that exhibits excellent histone acetyl transferase inhibitory activity against EP300 and/or CREBBP, or a pharmacologically acceptable salt thereof. The compound is represented by a specific formula, showcasing her innovative approach to addressing biochemical challenges.
Career Highlights
Akiko is currently associated with Daiichi Sankyo Company, Limited, where she continues to advance her research and development efforts. Her work has been instrumental in exploring new therapeutic avenues in the field of medicine.
Collaborations
Throughout her career, Akiko has collaborated with esteemed colleagues, including Hiroyuki Naito and Yoshiko Kagoshima. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
Akiko Egami's contributions to the field of histone acetyl transferase inhibition exemplify her dedication to innovation and research. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile